Elevance Health Inc. (ELV)
NYSE: ELV · IEX Real-Time Price · USD
500.12
-4.60 (-0.91%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Elevance Health Revenue
Elevance Health had revenue of $171.96B in the twelve months ending June 30, 2024, with 3.77% growth year-over-year. Revenue in the quarter ending June 30, 2024 was $43.89B with 0.49% year-over-year growth. In the year 2023, Elevance Health had annual revenue of $171.34B with 9.42% growth.
Revenue (ttm)
$171.96B
Revenue Growth
+3.77%
P/S Ratio
0.67
Revenue / Employee
$1,639,266
Employees
104,900
Market Cap
115.97B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 171.34B | 14.75B | 9.42% |
Dec 31, 2022 | 156.60B | 17.96B | 12.95% |
Dec 31, 2021 | 138.64B | 16.77B | 13.76% |
Dec 31, 2020 | 121.87B | 17.65B | 16.94% |
Dec 31, 2019 | 104.21B | 12.11B | 13.15% |
Dec 31, 2018 | 92.11B | 2.07B | 2.29% |
Dec 31, 2017 | 90.04B | 5.18B | 6.10% |
Dec 31, 2016 | 84.86B | 5.71B | 7.21% |
Dec 31, 2015 | 79.16B | 5.28B | 7.15% |
Dec 31, 2014 | 73.87B | 2.85B | 4.01% |
Dec 31, 2013 | 71.02B | 9.53B | 15.49% |
Dec 31, 2012 | 61.50B | 786.50M | 1.30% |
Dec 31, 2011 | 60.71B | 2.01B | 3.43% |
Dec 31, 2010 | 58.70B | -6.24B | -9.61% |
Dec 31, 2009 | 64.94B | 3.69B | 6.02% |
Dec 31, 2008 | 61.25B | 83.20M | 0.14% |
Dec 31, 2007 | 61.17B | 4.11B | 7.20% |
Dec 31, 2006 | 57.06B | 12.44B | 27.89% |
Dec 31, 2005 | 44.61B | 23.91B | 115.44% |
Dec 31, 2004 | 20.71B | 3.93B | 23.40% |
Dec 31, 2003 | 16.78B | 3.49B | 26.25% |
Dec 31, 2002 | 13.29B | 2.85B | 27.26% |
Dec 31, 2001 | 10.44B | 1.67B | 19.08% |
Dec 31, 2000 | 8.77B | 2.50B | 39.89% |
Dec 31, 1999 | 6.27B | 587.70M | 10.34% |
Dec 31, 1998 | 5.68B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cigna | 206.00B |
Pfizer | 55.09B |
Sanofi | 51.60B |
Medtronic | 32.36B |
Gilead Sciences | 27.45B |
Stryker | 20.96B |
Boston Scientific | 14.71B |
Regeneron Pharmaceuticals | 13.10B |
ELV News
- 3 days ago - BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations - Benzinga
- 4 days ago - Elevance Stock Slides Despite Earnings Beat as Medicaid Membership Declines - Investopedia
- 4 days ago - Elevance Health Beat Street Estimates On Q2 Profit And Revenue, Sticks To Annual Guidance - Benzinga
- 4 days ago - Elevance Health's Profits Hit $2.3 Billion Despite Drop In Medicaid Enrollees - Forbes
- 5 days ago - Elevance Health Reports Second Quarter 2024 Results - Business Wire
- 13 days ago - Elevance Health Releases Impact Report - Business Wire
- 25 days ago - Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2024 Results on July 17, 2024 - Business Wire
- 27 days ago - Morgan Stanley Says Elevance Health's Growth Attributed To Consistent Performance But Undervalued - Benzinga